Phacilitate conferences : Immuno-Oncology Frontiers / Cell & Gene Therapy Europe

The two Phacilitate conferences entitled Immuno-Oncology Frontiers and Cell & Gene Therapy Europe will be held from September the 20th to the 21st, 2017 in Berlin, Germany.

Stephan Reynier, Chief Regulatory and Compliance Officer at Cellectis, to take part in the Immuno-Oncology Frontiers conference on September the 20th from 3:50 PM to 4:05 PM with a presentation entitled "Engineered Allogeneic CAR T-cells Therapies: Lessons learned from Successful Regulatory Applications" during the session titled  "Immuno-Oncology: New targets and innovative ways to induce a better immune response". Stephan will also participate in the panel entitled "Keys to successfully navigating GMO regulations and environmental risk assessment (ERA) in Europe" that will be held from 4:45 PM to 6:15 PM on the same day. On September 21st, Stephan will also participate in a combination of organised networking and interactive presentations in the immuno-oncology networking area from 10:15 AM to 11 AM.